APA (7th ed.) Citation

X, X., X, C., R, X., Z, H., C, L., S, N., . . . M, D. (2026). Author Correction: Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-72371-2

Chicago Style (17th ed.) Citation

X, Xu, et al. "Author Correction: Combination of PARP and KRASG12D Inhibitors Enhances Therapeutic Efficacy by Exploiting Vulnerabilities in PDAC." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-72371-2.

MLA (9th ed.) Citation

X, Xu, et al. "Author Correction: Combination of PARP and KRASG12D Inhibitors Enhances Therapeutic Efficacy by Exploiting Vulnerabilities in PDAC." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-72371-2.